Menopausal Disorders (MD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Menopausal Disorders (MD) Marketed and Pipeline Drugs Report Overview
Menopausal disorders are a permanent cessation of menstruation resulting in the loss of ovarian follicle development. In 2023, the highest number of prevalent cases of menopausal disorders were registered in India and China. Treatment guidelines for MD are well-established globally and at the country level and are updated periodically. For instance, in 2023, the US and China updated guidelines. In the US, guidelines were provided by the North American Menopause Society while the Chinese Society of Obstetrics and Gynecology specified the same in China.
| Key Mechanism of Action (Marketed) | · Receptor Agonist
· Transporter Inhibitor · Receptor Antagonist · Enzyme Inhibitor |
| Key Routes of Administration (Marketed) | · Oral
· Topical · Injection · Suppository |
| Key Molecule Type (Marketed) | · Small Molecule
· Biologic |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
The Menopausal Disorders Marketed and Pipeline Drugs Market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, and pricing and reimbursement of therapy in major countries. Furthermore, the report analyzes late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA) for menopausal disorders.
The report also provides actionable insights on the clinical and commercial landscapes of menopausal disorders drugs, M&A deals, and market catalysts. These critical data will help you develop and design your in-licensing and out-licensing strategies. Furthermore, identify companies with the most robust pipelines to create smart business goals.
| Key Mechanisms of Action (Pipeline) | · Receptor Agonist
· Receptor Antagonist · Receptor Modulator · Ion Channel Inhibitor · Ion Channel Activator |
| Key Routes of Administration (Pipeline) | · Oral
· Suppository · Injection · Topical · Inhalational |
| Key Molecule Types (Pipeline) | · Small Molecules
· Biologics |
| Top Sponsors (Marketed and Pipeline Drugs) | · Bayer AG
· Astellas Pharma Inc. · Mayo Clinic · Mashhad University of Medical Sciences · Tehran University of Medical Sciences |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Menopausal Disorders Marketed Drugs Segmentation by Mechanisms of Action
The key MoA in the marketed drugs for menopausal disorders are receptor agonist, transporter inhibitor, receptor antagonist, and enzyme inhibitor among others. The majority of marketed drugs used for MD were receptor agonist in 2023, followed by transporter inhibitor.
Menopausal Disorders Marketed Drugs Analysis by Mechanisms of Action, 2023 (%)
Buy the Full Report to Know More about the MoA of men Menopausal Disorders Marketed Drugs
Menopausal Disorders Marketed Drugs Segmentation by Routes of Administration
Most of the menopausal disorders marketed drugs are orally administered. It is followed by topical, injectable, and suppository.
Menopausal Disorders Marketed Drugs Analysis by Routes of Administration, 2023 (%)
Buy the Full Report to Know More about the RoA of Menopausal Disorders Marketed Drugs
Menopausal Disorders Marketed Drugs Segmentation by Molecule Types
The key molecule types in the marketed drugs for menopausal disorders are small molecule and biologic. The majority of marketed drugs for MD were small molecules in 2023.
Menopausal Disorders Marketed Drugs Analysis by Molecule Types, 2023 (%)
Buy the Full Report to Know More about the Molecule Types of Menopausal Disorders Marketed Drugs
Menopausal Disorders Pipeline Drugs Market Segmentation by Mechanisms of Action
The key MoA in the Pipeline drugs for menopausal disorders are receptor agonist, receptor antagonist, receptor modulator, ion channel inhibitor, and ion channel activator. In 2023, receptor agonist was the leading MoA for menopausal disorders pipeline drugs.
Menopausal Disorders Pipeline Drugs Market Analysis by Mechanisms of Action, 2023 (%)
Buy Full Report to Know More about the MoA of Menopausal Disorders Pipeline Drugs
Menopausal Disorders Pipeline Drugs Market Segmentation by Routes of Administration
Most pipeline drugs for menopausal disorders followed oral RoA in 2023. The other popular routes of administration for MD are suppository, topical, inhalational, and injection.
Menopausal Disorders Pipeline Drugs Market Analysis by Routes of Administration, 2023 (%)
Buy Full Report to Know More about the RoA of Menopausal Disorders Pipeline Drugs
Menopausal Disorders Pipeline Drugs Market Segmentation by Molecule Types
The key molecule types in menopausal disorders pipeline drugs market are biologics and small molecules. In 2023, the pipeline of drugs for MD was dominated by small molecules type.
Menopausal Disorders Pipeline Drugs Market Analysis by Molecule Types, 2023 (%)
Buy the Full Report to Know More about the Molecule Types of Menopausal Disorders Pipeline Drugs
Menopausal Disorders Marketed and Pipeline Drugs Market – Competitive Landscape
A few of the top sponsors in the menopausal disorders marketed and pipeline drugs market are Bayer AG, Astellas Pharma Inc., Mayo Clinic, Mashhad University of Medical Sciences, and Tehran University of Medical Sciences. In 2023, Bayer AG conducted the highest number of completed trials, followed by Astellas Pharma Inc.
Menopausal Disorders Marketed and Pipeline Drugs Market Analysis by Sponsors, 2023 (%)
Buy Full Report for More Sponsor Insights into the Menopausal Disorders Marketed and Pipeline Drugs Market
Segments Covered in the Report
Menopausal Disorders Marketed Drugs Mechanism of Action (Number of Drugs, 2023)
- Receptor Agonist
- Transporter Inhibitor
- Receptor Antagonist
- Enzyme Inhibitor
Menopausal Disorders Marketed Drugs Routes of Administration Outlook (Number of Drugs, 2023)
- Injection
- Oral
- Topical
- Suppository
Menopausal Disorders Pipeline Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Receptor Agonist
- Receptor Antagonist
- Receptor Modulator
- Ion Channel Inhibitor
- Ion Channel Activator
Menopausal Disorders Pipeline Drugs Routes of Administration Outlook (Number of Drugs, 2023)
- Suppository
- Injection
- Oral
- Inhalational
- Topical
Menopausal Disorders Pipeline Drugs Molecule Types Outlook (Number of Drugs, 2023)
- Biologics
- Small Molecules
Scope
Components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Annual Therapy Cost
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the menopausal disorders market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global menopausal disorders market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
Which was the leading MoA for menopausal disorders marketed drugs in 2023?
The majority of marketed drugs used for MD were receptor agonist in 2023.
-
Which was the leading RoA for menopausal disorders marketed drugs in 2023?
In 2023, most of the marketed drugs for menopausal disorders were administered orally.
-
Which was the leading MoA for menopausal disorders pipeline drugs in 2023?
In 2023, receptor agonist was the leading MoA for menopausal disorders pipeline drugs.
-
Which was the leading RoA for menopausal disorders pipeline drugs in 2023?
Most pipeline drugs for menopausal disorders followed oral RoA in 2023.
-
Which was the leading molecule type for menopausal disorders pipeline drugs in 2023?
In 2023, the pipeline of drugs for MD was dominated by small molecule type.
-
Who are the top sponsors for the menopausal disorders marketed and pipeline drugs market?
A few of the top sponsors in the menopausal disorders marketed and pipeline drugs market are Bayer AG, Astellas Pharma Inc., Mayo Clinic, Mashhad University of Medical Sciences, and Tehran University of Medical Sciences.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Sample Report
Menopausal Disorders (MD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
Related reports
View more Menopausal Disorders reports